Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.
Yamamoto A, Kawashima A, Sakai S, Mita M, Sassi N, Inoguchi S, Horibe Y, Yoshimura A, Tani M, Yutong L, Okuda Y, Oka T, Uemura T, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Hatano K, Kakuta Y, Imamura R, Takahara S, Kimura T, Nonomura N. Yamamoto A, et al. Among authors: uemura t. Biochem Biophys Res Commun. 2024 Nov 12;733:150701. doi: 10.1016/j.bbrc.2024.150701. Epub 2024 Sep 14. Biochem Biophys Res Commun. 2024. PMID: 39326256 Free article.
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Jingushi K, Kawashima A, Saito T, Kanazawa T, Motooka D, Kimura T, Mita M, Yamamoto A, Uemura T, Yamamichi G, Okada K, Tomiyama E, Koh Y, Matsushita M, Kato T, Hatano K, Uemura M, Tsujikawa K, Wada H, Nonomura N. Jingushi K, et al. Among authors: uemura m, uemura t. Cancer Immunol Immunother. 2022 Dec;71(12):2999-3011. doi: 10.1007/s00262-022-03213-5. Epub 2022 May 22. Cancer Immunol Immunother. 2022. PMID: 35598195 Free PMC article.
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.
Tomiyama E, Fujita K, Matsuzaki K, Narumi R, Yamamoto A, Uemura T, Yamamichi G, Koh Y, Matsushita M, Hayashi Y, Hashimoto M, Banno E, Kato T, Hatano K, Kawashima A, Uemura M, Ukekawa R, Takao T, Takada S, Uemura H, Adachi J, Tomonaga T, Nonomura N. Tomiyama E, et al. Among authors: uemura m, uemura h, uemura t. Br J Cancer. 2022 Oct;127(7):1312-1323. doi: 10.1038/s41416-022-01860-0. Epub 2022 Jul 6. Br J Cancer. 2022. PMID: 35794239 Free PMC article.
Anticancer maintenance chemotherapy prolonged prognosis of metastatic urothelial carcinoma patients: A single institute retrospective study using propensity score matching.
Yamamoto A, Kawashima A, Uemura T, Yamamichi G, Tomiyama E, Koh Y, Matsushita M, Kato T, Hatano K, Uemura M, Imamura R, Nonomura N. Yamamoto A, et al. Among authors: uemura m, uemura t. Int J Urol. 2022 Nov;29(11):1294-1303. doi: 10.1111/iju.14987. Epub 2022 Aug 24. Int J Urol. 2022. PMID: 36000588
The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.
Oka T, Hatano K, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Tomiyama E, Ishizuya Y, Yamamoto Y, Kato T, Kawashima A, Fujita K, Nonomura N. Oka T, et al. Among authors: uemura t. Int J Clin Oncol. 2023 Mar;28(3):427-435. doi: 10.1007/s10147-022-02288-5. Epub 2022 Dec 29. Int J Clin Oncol. 2023. PMID: 36580184
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma.
Uemura T, Kawashima A, Jingushi K, Motooka D, Saito T, Nesrine S, Oka T, Okuda Y, Yamamoto A, Yamamichi G, Tomiyama E, Ishizuya Y, Yamamoto Y, Kato T, Hatano K, Tsujikawa K, Wada H, Nonomura N. Uemura T, et al. Heliyon. 2023 Sep 6;9(9):e19800. doi: 10.1016/j.heliyon.2023.e19800. eCollection 2023 Sep. Heliyon. 2023. PMID: 37810127 Free PMC article.
1,488 results